These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 11207056)

  • 41. Focal inhibitory interneuron loss and principal cell hyperexcitability in the rat hippocampus after microinjection of a neurotoxic conjugate of saporin and a peptidase-resistant analog of Substance P.
    Martin JL; Sloviter RS
    J Comp Neurol; 2001 Jul; 436(2):127-52. PubMed ID: 11438920
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Establishment of a human t(4;11) leukemia in severe combined immunodeficient mice and successful treatment using anti-CD19 (B43)-pokeweed antiviral protein immunotoxin.
    Jansen B; Uckun FM; Jaszcz WB; Kersey JH
    Cancer Res; 1992 Jan; 52(2):406-12. PubMed ID: 1370213
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ATG-saporin-S6 immunotoxin: a new potent and selective drug to eliminate activated lymphocytes and lymphoma cells.
    Polito L; Bortolotti M; Farini V; Pedrazzi M; Tazzari PL; Bolognesi A
    Br J Haematol; 2009 Dec; 147(5):710-8. PubMed ID: 19764990
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development of a severe combined immunodeficiency (SCID) mouse model consisting of highly disseminated human B-cell leukemia/lymphoma, cure of the tumors by systemic administration of immunotoxin, and development/application of a clonotype-specific polymerase chain reaction-based assay.
    Yoshida M; Rybak RJ; Choi Y; Greenberg SJ; Barcos M; Kawata A; Matsuno F; Tsai H; Seon BK
    Cancer Res; 1997 Feb; 57(4):678-85. PubMed ID: 9044845
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Delivery of the ribosome-inactivating protein, gelonin, to lymphoma cells via CD22 and CD38 using bispecific antibodies.
    French RR; Penney CA; Browning AC; Stirpe F; George AJ; Glennie MJ
    Br J Cancer; 1995 May; 71(5):986-94. PubMed ID: 7734325
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain.
    Ramakrishnan S; Houston LL
    Cancer Res; 1984 Apr; 44(4):1398-404. PubMed ID: 6142765
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protein-tyrosine phosphorylation by IgG1 subclass CD38 monoclonal antibodies is mediated through stimulation of the FcgammaII receptors in human myeloid cell lines.
    Inoue S; Kontani K; Tsujimoto N; Kanda Y; Hosoda N; Hoshino S; Hazeki O; Katada T
    J Immunol; 1997 Dec; 159(11):5226-32. PubMed ID: 9548461
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Engineered anti-CD38 monoclonal antibodies for immunotherapy of multiple myeloma.
    Ellis JH; Barber KA; Tutt A; Hale C; Lewis AP; Glennie MJ; Stevenson GT; Crowe JS
    J Immunol; 1995 Jul; 155(2):925-37. PubMed ID: 7608568
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synergistic potentiation of in vivo antitumor activity of anti-human T-leukemia immunotoxins by recombinant alpha-interferon and daunorubicin.
    Yokota S; Hara H; Luo Y; Seon BK
    Cancer Res; 1990 Jan; 50(1):32-7. PubMed ID: 2293557
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The TLR3 Agonist Poly Inosinic:Cytidylic Acid Significantly Augments the Therapeutic Activity of an Anti-CD7 Immunotoxin for Human T-cell Leukaemia.
    Flavell DJ; Holmes SE; Warnes SL; Flavell SU
    Biomedicines; 2019 Feb; 7(1):. PubMed ID: 30781517
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An anti-CD72 immunotoxin against therapy-refractory B-lineage acute lymphoblastic leukemia.
    Myers DE; Uckun FM
    Leuk Lymphoma; 1995 Jun; 18(1-2):119-22. PubMed ID: 8580813
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Coordinated regulation in human T cells of nucleotide-hydrolyzing ecto-enzymatic activities, including CD38 and PC-1. Possible role in the recycling of nicotinamide adenine dinucleotide metabolites.
    Deterre P; Gelman L; Gary-Gouy H; Arrieumerlou C; Berthelier V; Tixier JM; Ktorza S; Goding J; Schmitt C; Bismuth G
    J Immunol; 1996 Aug; 157(4):1381-8. PubMed ID: 8759717
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunotherapeutic strategies in neuroblastoma: antitumoral activity of deglycosylated Ricin A conjugated anti-GD2 antibodies and anti-CD3xanti-GD2 bispecific antibodies.
    Manzke O; Russello O; Leenen C; Diehl V; Bohlen H; Berthold F
    Med Pediatr Oncol; 2001 Jan; 36(1):185-9. PubMed ID: 11464879
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effective therapy for a murine model of adult T-cell leukemia with the humanized anti-CD52 monoclonal antibody, Campath-1H.
    Zhang Z; Zhang M; Goldman CK; Ravetch JV; Waldmann TA
    Cancer Res; 2003 Oct; 63(19):6453-7. PubMed ID: 14559836
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunotoxin mediated killing of clonable T-lymphocytes infiltrating an irreversibly rejected human renal allograft.
    Siena S; Bregni M; Formosa A; Brando B; Lappi DA; Bonadonna G; Gianni AM
    J Biol Regul Homeost Agents; 1989; 3(2):84-8. PubMed ID: 2479229
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Polynucleotide: adenosine glycosidase activity of immunotoxins containing ribosome-inactivating proteins.
    Barbieri L; Bolognesi A; Valbonesi P; Polito L; Olivieri F; Stirpe F
    J Drug Target; 2000; 8(5):281-8. PubMed ID: 11328656
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma.
    Lopes de Menezes DE; Pilarski LM; Allen TM
    Cancer Res; 1998 Aug; 58(15):3320-30. PubMed ID: 9699662
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunotoxin-mediated inhibition of chronic lymphocytic leukemia cell proliferation in humans.
    Siena S; Bregni M; Formosa A; Brando B; Marenco P; Lappi DA; Bonadonna G; Gianni AM
    Cancer Res; 1989 Jun; 49(12):3328-32. PubMed ID: 2785850
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Visualization of immunotoxin-mediated tumor cell death in vivo.
    Erickson HA; Reinhardt RL; Hermanson JB; Panoskaltsis-Mortari A; Pennell CA
    Clin Cancer Res; 2001 Mar; 7(3 Suppl):890s-894s. PubMed ID: 11300488
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An immunotoxin made up with campath 1 and saporin 6: preliminary "in vitro" experience.
    Gobbi M; Barbieri L; Tazzari PL; Dinota A; Bontadini A; Rizzi S; Pession A; Stirpe F; Tura S
    J Exp Pathol; 1987; 3(4):359-62. PubMed ID: 3331647
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.